Wang, Xiaoli <br/><br/>
Imetelstat, a telomerase inhibitor, is capable of depleting myelofibrosis stem and progenitor cells.  [electronic resource] 

 -  Blood advances  09 2018 
 - 2378-2388 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2473-9537 
<br/><br/><label>Standard No.: </label>10.1182/bloodadvances.2018022012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--genetics<br/>Biomarkers<br/>Calreticulin--genetics<br/>Cell Differentiation--drug effects<br/>Enzyme Inhibitors--pharmacology<br/>Hematopoietic Stem Cells--drug effects<br/>Janus Kinase 2--genetics<br/>Mice<br/>Mice, Knockout<br/>Mice, Transgenic<br/>Myeloid Progenitor Cells--drug effects<br/>Oligonucleotides--pharmacology<br/>Primary Myelofibrosis--drug therapy<br/>Telomerase--antagonists & inhibitors